Workflow
微芯生物披露2024年度向特定对象发行A股股票审核问询函回复,发行进程存不确定性

Group 1 - The company Shenzhen Micu Biotechnology Co., Ltd. announced on September 25, 2025, regarding the response to the inquiry letter for the application of issuing A-shares to specific objects for the year 2024 [1] - On September 1, 2025, the company received an inquiry letter from the Shanghai Stock Exchange regarding the application for issuing A-shares to specific objects [1] - The issuance of A-shares is subject to approval from the Shanghai Stock Exchange and registration consent from the China Securities Regulatory Commission, with uncertainties regarding the approval timeline [1] Group 2 - The company will fulfill its information disclosure obligations in a timely manner based on the progress of the matter, reminding investors to pay attention to investment risks [1]